Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CoolTouch is a medical device company specializing in the development and manufacturing of innovative laser systems for aesthetic and surgical applications. The company is best known for its pioneering work in endovenous laser ablation (EVLA) for the treatment of varicose veins and its non-ablative laser technology for skin rejuvenation and acne. Its product portfolio includes the CoolTouch CTEV, CoolLipo, and CoolTouch VARIA systems, which utilize specific wavelengths to target vascular and dermatological conditions with minimal downtime. Acquired by Syneron Medical in 2014, CoolTouch's technologies continue to be a staple in the portfolios of aesthetic practitioners worldwide. The company's 1320 nm laser was notably the first FDA-cleared laser for non-ablative wrinkle reduction, marking a significant milestone in cosmetic dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CoolTouch.